Evidence map›Paper›PMID 40345232›Full record

ArticleImmunoHorizons2025

Dynamics of antimicrobial proteins' expression and their bactericidal activity in mouse milk.

Piu Saha, Ahmed Abokor, Matam Vijay-Kumar

Abstract read
In one paragraph

Article in ImmunoHorizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Piu SahaDepartment of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.ORCID 0000-0003-0626-398X
Ahmed AbokorDepartment of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Matam Vijay-KumarDepartment of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.ORCID 0000-0002-8732-0167

Funding

American Heart Association 855256Crohn's and Colitis Foundation 854385Matam Vijay-Kumar R01CA219144NIH HHS
6 · The paper itself

Abstract

Mother's milk is considered as "complete edible immune system." It contains macro- and micronutrients required to maintain infant growth and provides an excellent source for innate and adaptive immune proteins that not only protects infants from enteropathogens but also aid in the initial colonization of gut microbiota. In this study, we analyzed the milk of C57BL/6J dams and found significant changes in the composition of antimicrobial and immune proteins throughout the lactation period. Innate immune proteins, serum amyloid A, soluble CD14, and notably lipocalin-2 were detected in milk at high quantities. These proteins were substantially reduced in the milk from MyD88-deficient dams. Further, adaptive immune proteins, specifically IgA and IgG, exhibit a distinct shift during postpartum lactation stages. While IgG is the dominant immunoglobulin in milk at day 5 postpartum, by day 15 its levels were surpassed by IgA whose levels increased over time. The administration of TLR4 ligand LPS to WT dams significantly increased the aforementioned milk innate and adaptive proteins. Surprisingly, the milk from WT dams suppressed E. coli growth more effectively than milk collected from LPS-treated mice; such suppression, however, was completely lost upon boiling. Intriguingly, IgA, but not Lcn2, serves as a predominant factor in inhibiting E. coli proliferation, suggesting the critical role of IgA in regulating microbial colonization in the neonatal gut. Collectively, our findings provide insight into the dynamics of various immune proteins present in breast milk and highlight their pivotal roles in determining neonatal immune responses and microbial colonization at early stage.

Indexed as

MilkAnimalsEscherichia coliFemaleImmunity, InnateImmunoglobulin AImmunoglobulin GLactationLipocalin-2Lipopolysaccharide ReceptorsLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88Serum Amyloid A ProteinImmunoglobulin AImmunoglobulin GLcn2 protein, mouseLipocalin-2Lipopolysaccharide ReceptorsLipopolysaccharidesMyd88 protein, mouseMyeloid Differentiation Factor 88Serum Amyloid A ProteinE. coliIgAIgGlipocalin-2serum amyloid A

Identifiers

PMID40345232
PMCPMC12064171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.